19 May 2021
Leading with evidence, latest clinical outcomes update for Firesorb, Firehawk and VitaFlow
Sponsored by MicroPort
Facilitator:
A. Lansky
Chatmaster:
A. Baumbach
Summary
Watch this session presented by Alexandra Lansky, Andreas Baumbauch, Junbo Ge and Bo Xu in order to learn about the one-year results from a pivotal RCT (FUTURE II), the four-year results from TARGET AC, and the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic stenosis.
Learning Objectives
- To know the one-year results from a pivotal RCT (FUTURE II)
- To know the four-year results from TARGET AC
- To know the four-year results from VitaFlow transcatheter aortic valve system in patients with severe aortic stenosis